Overview
The Consortium for Clinical Research and Innovation, Singapore (CRIS) brings together seven national R&D, clinical translation and service programmes to advance clinical research and innovation for Singapore, and establish important capabilities for a future-ready healthcare system.
The Business Entities under CRIS include:
- Singapore Clinical Research Institute (SCRI)
- National Health Innovation Centre (NHIC)
- Advanced Cell Therapy and Research Institute, Singapore (ACTRIS)
- Precision Health Research, Singapore (PRECISE)
- Singapore Translational Cancer Consortium (STCC)
- Cardiovascular Disease National Collaborative Enterprise (CADENCE)
- Singapore Medical Foundation AI model (SIMFONI)
Together, CRIS makes a positive difference to Singapore patients and researchers by ensuring that these clinical research platforms and programmes are at the cutting edge of capability development and innovation. If you are as passionate as we are in clinical trials and research, we want you!
CADENCE
The Cardiovascular Disease National Collaborative Enterprise (CADENCE) is a national program for Cardiovascular Research that aims to strengthen the overall impact of cardiovascular research and translation in Singapore through: (1) synergising efforts across Singapore through the establishment of Joint Platforms to improve patient outcomes and establish Singapore as a global leader in cardiovascular disease (CVD) research; (2) overcoming common barriers to research at the systems level; (3) driving commercialisation efforts; and (4) demonstrating the power of these synergies through a series of practice-changing Use Cases.
CADENCE will be housed as a business unit within the Consortium for Clinical Research and Innovation Singapore (CRIS), a wholly-owned subsidiary of the Ministry of Health Holdings (MOHH) Pte Ltd and anchored by the CVD research programmes and commercialization platforms of partner institutions (MOHT, NHCS & NHRIS, NUHCS & CVRI, NHG Heart Institute, KTPH, A*STAR, NUS, Duke-NUS, LKC).
What you will be working on
The Assistant Director (Scientific & Strategy) serves as the intellectual and operational engine of CADENCE, the National Clinical Translational Programme for cardiovascular research. Reporting to the Executive and Co-Directors, this role is responsible for shaping Singapore's national cardiovascular research roadmap, translating scientific discoveries into fundable strategic initiatives, and governing research portfolios across the programme's joint platforms and partnerships. The successful candidate will align scientific excellence with fiscal and strategic objectives to maximise the consortium's healthcare impact, while establishing Singapore as the leading Asian hub for high-impact cardiovascular research. The ideal candidate is a visionary scientific leader with deep expertise in cardiovascular research, a strong record of multi-institutional collaboration, and the ability to convert scientific strategy into competitive, funded programmes.